Formative Test.

Slides:



Advertisements
Similar presentations
Agents Used in the Treatment of Hyperlipidemia
Advertisements

Drugs in dyslipidaemias
Drugs and Dyslipidemias (statins and other lipid and atherosclerosis-modifying drugs) October 18, 2006 Frank F. Vincenzi.
Diagnosis and Treatment of Dyslipidemia  New guidelines are based on the “Adult Treatment Plan III (ATP III)” 2004  Focus = multiple risk factor assessment.
Treatment of Dyslipidemia SDPI CGP Healthy Heart Project March 8, 2006.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 50 Prophylaxis of Coronary Heart Disease: Drugs That Help Normalize Cholesterol.
Anti-Hypercholesterolemic Agents  Biosynthesis and Metabolism of Cholesterol  What is arteriosclerosis? - Link between arteriosclerosis and cholesterol.
ANTILIPEMICS LILLEY, READING & WORKBOOK: CHAP 28 Cardiovascular System.
Pharmacology of Agents Used in Hyperlipidemia
HYPERLIPIDEMIAS  Conditions in which the concentrations of cholesterol or triglyceride carrying lipoproteins exceed arbitrary normal limits.
Antiatherosclerosis drugs. Lipid-regulating drugs  Background  Lipoprotein  Classification of Lipoprotein: CM 、 VLDL 、 IDL 、 LDL 、 HDL 、 Lp(a) CM 、
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 29 Antilipemic Drugs.
The Antihyperlipidemic Medications l Classifications of Lipoproteins – Chylomicrons l Formed in the mucosal cells of the gut l Protein coated dietary lipids.
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display. 1 CHAPTER 29 Hypolipidemic Drugs.
Kirk Mykytyn, Ph.D. Department of Pharmacology
Department of Family & Community Medicine
Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium sized arteries.
Hyperlipidemia Hyperlipoproteinemia Hyperlipoproteinemia (cholesterol, Triglyceride, LDL-C, VLDL) Lead to atherosclerosis and Coronary artery disease.
ANTIHYPERLIPIDEMIC DRUGS
Hperlipidemia:- Treatment and Management Presented by:- Dr. Tewari.
Management & Medications  Diet, weight loss and drug therapy are the mainstay of treatment, while exercise training is used as adjunctive therapy  Lipid-lowering.
Drug therapy for Dyslipidemias
Antihyperlipidemic drugs The clinically important lipoproteins are LDL low density lipoprotein, VLDL very low density lipoprotein, HDL high density lipoprotein.
Part 5 Antiatheroscleotic drugs. §Plasma lipids § Cholesterol free cholesterol (FC) § cholesterolester (CE) § Triglyceride (TG) § Phospholipid (PL)
Case 15 Andrea De Mesa. Patient history A 44 y/o male, single, undergoes cardiovascular screening on advice of his attending physician. He is a smoker.
Chapter 19 Agents Used to Treat Hyperlipidemia. Hyperlipidemia 2 Atherosclerosis – accumulation of fatty substances on the inner wall of large and medium.
Jiří Slíva, M.D. statins (inhibitors of HMG-CoA reductase) fibrates anion - exchange resins nicotinic acid group.
HYPERLIPIDEMIA Applied Therapeutics Dr. Riyadh Mustafa Al-Salih.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 28 Antilipemic Drugs.
Hyperlipidemia Hyperlipidemia and hyperlipoproteinemia are general terms for elevated concentrations of lipids and lipoproteins in the blood. hypercholesterolemia.
Management of Hyperlipoprotinaemia
1 HYPOLIPIDAEMICS or LIPID LOWERING DRUGS. 2 Hypolipidaemic agents, or antihyperlipidemic agents, are a diverse group of pharmaceuticals that are used.
Chapter 21 Agents Used in the Treatment of Hyperlipidemia.
Drugs Used to Treat Dyslipidemias Chapter 22 Mosby items and derived items © 2010, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc.
Learning Objectives How does hyperlipemia differ from hyperlipoproteinemia? What are the atherogenic lipoproteins? Describe the major characteristics.
Anti hyperlipidemic drugs (lipid lowering drugs) Department of Pharmacology Faculty of Medicine AIMST UNIVERSITY 5 September 2012.
HYPERLIPIDEMIA  Coronary heart disease (CHD) is the cause of about half of all deaths. The incidence of CHD is correlated with elevated levels of low-density.
50 Drugs that Help Normalize Cholesterol & Triglyceride Levels
Overview Lipoprotein metabolism Digestive lipid metabolism
Prophylaxis of Coronary Heart Disease: Drugs That Help Normalize Cholesterol and Triglyceride Levels.
Drugs Used in Hyperlipidemia
Atorvastatin Calcium Atorvastatin Calcium is an inhibitor of HMG-CoA reductase used as a cholesterol-lowering medication that blocks the production of.
Antihyperlipidemic Drugs
Cholesterol metabolism
Hypolipidemic Drugs Classification:
Drugs for hyperlipidemia
Hyperlipidemias.
أبدا لم يفت الاوان لكي تبدأ
Drugs for Lipid Disorders
Statins induced myopathy
Drugs for hyperlipidemia
Anti-Hypercholesterolemic Agents
By: Dr Israa Omar MBBS, MRCP, MSc pharmacology
Drugs for Hyperlipidemia
Applied Therapeutics Dr. Riyadh Mustafa Al-Salih
Anti-Hypercholesterolemic Agents  Biosynthesis and Metabolism of Cholesterol  What is arteriosclerosis? - Link between arteriosclerosis and cholesterol.
Antihyperlipidemic Drugs
Anti-Hypercholesterolemic Agents
Drugs for Hyperlipidemias
Biosynthesis and Metabolism of Cholesterol
Antilipidaemic agents
Antihyperlipidemic Drugs
Cardiovascular System
Antilipemic Agents Lilley Pharmacology Text: Chapter 27
Lecture 5b 7 Feb 2011 Atherosclerosis-Nutritional intervention-
Major classes of drugs to reduce lipids
Drugs for Hyperlipidemia
Lipoproteins   Macromolecular complexes in the blood that transport lipids Apolipoproteins   Proteins on the surface of lipoproteins; they play critical.
Hyperlipidemia (Hyperlipoproteinaemia) (Dyslipidemia) By Ahmed M
ATP III Guidelines Drug Therapy FUTURE RESEARCH.
Presentation transcript:

Formative Test

Q1- Anti-lipid drug that usually causes cutaneous vasodilation after each dose when the drug is started A- gemfibrozil      B- niacin      c- cholestyramine d-  clofibrate    e-  lovastatin

A- clofibrate B- gemfibrozil C- cholestyramine D- pravastatin Q2- Antilipidemic drug most likely to reduce serum digoxin levels: A- clofibrate   B- gemfibrozil C- cholestyramine D- pravastatin E- niacin

Q3- 54-year-old woman with severe hypercholesterolemia is to be treated with a combination of niacin and atorvastatin. With this drug combination, it is important that the patient be monitored closely for signs of:- (A) Agranulocytosis (B) Gallstones (C) Lactic acidosis (D) Myopathy (E) Thyrotoxicosis

Q4-A 35year- old male with markedly elevated plasma triglycerides and LDL levels is treated with gemfibrozil. What is the mechanism of action of gemfibrozil? Sequestration of bile acids Decreased hepatic secretion of VLDL Increased lipoprotein lipase activity Inhibition of HMG-CoA reductase Decreased oxidation of plasma lipids

Q5-Which of the following drugs recommended for the lowering of blood cholesterol inhibits the synthesis by blocking 3-hydroxy-3-methylglutaryl coenzyme A reductase? Gemfibrozil Niacin Ezetimibe Atorvastatin Cholestyramine